Literature DB >> 19968822

H19 RNA downregulation stimulated melanogenesis in melasma.

Nan-Hyung Kim1, Chang-Hoon Lee, Ai-Young Lee.   

Abstract

A variety of factors, including ultraviolet (UV) exposure, have been implicated in the pathogenesis of melasma. However, UV-induced hyperpigmentation usually recovers spontaneously, whereas melasma does not. Recently, we detected downregulation of the H19 gene on microarray analysis of hyperpigmented and normally pigmented skin from patients with melasma, and identified significant clinical correlations. The H19 downregulation was not accompanied by a reciprocal change of the imprinted gene, insulin-like growth factor II. Moreover, methylation pattern of the H19 promoter region in maternal ICR was variable. The H19 knockdown in melanocyte monoculture did not result in obvious tyrosinase overexpression, whereas the knockdown in a mixed cell culture system, composed of H19 siRNA transfected normal human keratinocytes and non-transfected normal human melanocytes, did induce not only a tyrosinase overexpression but also an increase of melanosome transfer. Estrogen treatment of the H19 RNA knockdown in the mixed cell culture was more than an additive effect on the tyrosinase overexpression, whereas UV irradiation was not. These findings suggest that downregulation of H19 and a sufficient dose of estrogen might be involved in the development of melasma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968822     DOI: 10.1111/j.1755-148X.2009.00659.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  15 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  Reduced MiR-675 in exosome in H19 RNA-related melanogenesis via MITF as a direct target.

Authors:  Nan-Hyung Kim; Soo-Hyun Choi; Chang-Hyun Kim; Chang Hoon Lee; Tae Ryong Lee; Ai-Young Lee
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

3.  The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth.

Authors:  Cibele Cardoso; Rodolfo B Serafim; Akinori Kawakami; Cristiano Gonçalves Pereira; Jason Roszik; Valeria Valente; Vinicius L Vazquez; David E Fisher; Enilza M Espreafico
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-16       Impact factor: 4.693

4.  Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma.

Authors:  Nan-Hyung Kim; Soo-Hyun Choi; Tae Ryong Lee; Chang-Hoon Lee; Ai-Young Lee
Journal:  J Invest Dermatol       Date:  2014-06-14       Impact factor: 8.551

Review 5.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

Review 6.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Melasma update.

Authors:  Rashmi Sarkar; Pooja Arora; Vijay Kumar Garg; Sidharth Sonthalia; Narendra Gokhale
Journal:  Indian Dermatol Online J       Date:  2014-10

8.  Evidence-based treatment for melasma: expert opinion and a review.

Authors:  Krupa Shankar; Kiran Godse; Sanjeev Aurangabadkar; Koushik Lahiri; Venkat Mysore; Anil Ganjoo; Maya Vedamurty; Malavika Kohli; Jaishree Sharad; Ganesh Kadhe; Pashmina Ahirrao; Varsha Narayanan; Salman Abdulrehman Motlekar
Journal:  Dermatol Ther (Heidelb)       Date:  2014-10-01

9.  Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.

Authors:  Siqi Wang; Wenliang Fan; Bing Wan; Mengqi Tu; Feng Jin; Fang Liu; Haibo Xu; Ping Han
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

10.  Involvement of Transglutaminase-2 in α-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells.

Authors:  Hyun Ji Kim; Hye Ja Lee; Mi Kyung Park; Kyung Jin Gang; Hyun Jung Byun; Jeong Ho Park; Mi Kyung Kim; Soo Youl Kim; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.